The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment

被引：7
|
作者：
Das, Sanjna [1 ]
Hayden, Joshua [2 ]
Sullivan, Travis [1 ]
Rieger-Christ, Kimberly [1 ]
机构：
[1] Lahey Hosp & Med Ctr, Dept Translat Res, Burlington, MA 01805 USA
[2] Lahey Hosp & Med Ctr, Dept Urol, Burlington, MA 01805 USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2023年 / 24卷 / 02期
关键词：
bladder cancer (BCa); recurrence; chemoresistance; miRNA; EMT; cell cycle; fatty acid metabolism; Wnt; HIPPO; FGFR3; EPITHELIAL-MESENCHYMAL TRANSITION; MICRORNA EXPRESSION SIGNATURES; MULTI-CHEMORESISTANCE; DOWN-REGULATION; CISPLATIN-RESISTANCE; CELL-PROLIFERATION; SIGNALING PATHWAY; NONINVASIVE BIOMARKERS; WNT/BETA-CATENIN; FGFR3; EXPRESSION;
D O I：
10.3390/ijms24020964
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Bladder cancer (BCa) is associated with significant morbidity, with development linked to environmental, lifestyle, and genetic causes. Recurrence presents a significant issue and is managed in the clinical setting with intravesical chemotherapy or immunotherapy. In order to address challenges such as a limited supply of BCG and identifying cases likely to recur, it would be advantageous to use molecular biomarkers to determine likelihood of recurrence and treatment response. Here, we review microRNAs (miRNAs) that have shown promise as predictors of BCa recurrence. MiRNAs are also discussed in the context of predicting resistance or susceptibility to BCa treatment.
引用
收藏
页数：17
相关论文
共 50 条
  • [21] A FOUR MIRNAS SIGNATURE AS A POTENTIAL BIOMARKER FOR PREDICTING SURVIVAL USING BIOINFORMATICS ANALYSIS IN BLADDER CANCER
    Xiao, He
    Chen, Ping
    Xu, Deqiang
    DiSanto, Michael E.
    Zhang, Xinhua
    JOURNAL OF UROLOGY, 2018, 199 (04): : E777 - E777
  • [22] Bladder Cancer: Aspirin reduces bladder cancer recurrence
    Hay A.M.
    Nature Reviews Urology, 2009, 6 (5) : 243 - 243
  • [23] Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Using European Organization of Research and Treatment of Cancer Risk Tables
    Ather, M. Hammad
    Zaidi, Masooma
    UROLOGY JOURNAL, 2009, 6 (03) : 189 - 193
  • [24] CURRENT AND FUTURE ROLES OF CHEMOTHERAPY IN THE TREATMENT OF BLADDER-CANCER
    RAGHAVAN, D
    BRITISH JOURNAL OF UROLOGY, 1983, 55 (01): : 107 - 107
  • [25] miRNAs in oral cancer; diagnostic and prognostic roles
    Arabi, Kimia
    Salman, Bahareh Nazemi
    Rahimzadeh-Bajgiran, Fatemeh
    Moghbeli, Meysam
    Moghadas, Sepehr
    Saburi, Ehsan
    GENE, 2025, 951
  • [26] Roles of miRNAs in regulating ovarian cancer stemness
    Chong, Zhi-Xiong
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (06):
  • [27] Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer
    Abugomaa, Amira
    Elbadawy, Mohamed
    Yamawaki, Hideyuki
    Usui, Tatsuya
    Sasaki, Kazuaki
    CELLS, 2020, 9 (01)
  • [28] Nomogram for Predicting Risk of Cystectomy or Recurrence after Bladder Preserving Trimodality Therapy for Muscle Invasive Bladder Cancer
    Coen, J.
    Paly, J. J.
    Efstathiou, J. A.
    Niemierko, A.
    Kaufman, D. S.
    Heney, N. M.
    Spiegel, D. Y.
    Zietman, A. L.
    Shipley, W. U.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S71 - S71
  • [29] Emerging roles of miRNAs in the development of pancreatic cancer
    Fathi, Mohadeseh
    Ghafouri-Fard, Soudeh
    Abak, Atefe
    Taheri, Mohammad
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
  • [30] miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer
    Cai, Zhonglin
    Zhang, Fa
    Chen, Weijie
    Zhang, Jianzhong
    Li, Hongjun
    ONCOTARGETS AND THERAPY, 2019, 12 : 1805 - 1816
12345